This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies
joint with Purinergic Signaling
Organizer(s): Barbara Seliger, Jerome Galon and Francesco M. Marincola
Date: January 24 - 28, 2016
Location: Fairmont Hotel Vancouver, Vancouver, BC, Canada
Sponsored by BioLegend, Inc., Genentech, Inc., Genmab A/S, ImmunoGen, Inc., Incyte Corporation, Infinity Pharmaceuticals, Inc., Merck & Co., Inc., Mersana Therapeutics, MorphoSys AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi US, Shire Human Genetic Therapies and Thermo Fisher Scientific Inc.
Summary of Meeting:
This meeting focuses on immune escape mechanisms, immune tolerance, the role of immune effector and suppressor cells as well as the tumor microenvironment in this context, and the modulation of these different processes. In addition, the modes and efficacy of different cancer immunotherapeutic strategies and targeted therapies alone and in combination as well as their influence on the immune escape and immune suppressive activity will be an important topic. This meeting is expected to attract a broad range of scientists (e.g., biologists, biochemists, immunologists, cancer researchers) and clinicians (oncologists, pathologists, radiologists) and will bridge basic, translational and clinical research. The speakers invited represent basic researchers, clinicians and employees of the pharmaceutical industry. There will be a strong clinical focus to the program, in particular regarding different therapeutic strategies including cancer immunotherapy and targeted therapies, which have recently been successfully implemented for the therapy of many cancers including chronic myeloid leukemia, breast carcinoma, non-small lung carcinoma, colorectal cancer, kidney cancer and melanoma.
Scholarship Deadline: September 29 2015
Discounted Abstract Deadline: September 29 2015
Abstract Deadline: October 29 2015
Discounted Registration Deadline: November 24 2015
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
BioLegend, Inc.Genentech, Inc.Genmab A/SImmunoGen, Inc.Incyte CorporationInfinity Pharmaceuticals, Inc.Merck & Co., Inc.Mersana TherapeuticsMorphoSys AGPfizer Inc.Regeneron Pharmaceuticals, Inc.Sanofi USShire Human Genetic TherapiesThermo Fisher Scientific Inc.
We gratefully acknowledge additional support for this conference from:
Bio-TechneCharles River LaboratorieseBioscience, an Affymetrix companyNanoString Technologies
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Juno Therapeutics
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found